NEW YORK, Oct 16 - DoubleTwist, next in the bioinformatics IPO queue, is seeking to raise at least $65 million through an offer of 5 million shares in a proposed price range of $13 to $15 a share, according to an S-1 amendment the company filed Friday.

The company, which originally announced its plan to go public on Sept. 1, has applied to be listed on the Nasdaq under the symbol DBLT. A DoubleTwist spokeswoman said that the date the company's stock would begin trading has not yet been determined.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.